Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506
- PMID: 8887267
- DOI: 10.1038/ki.1996.417
Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506
Abstract
Acute cyclosporine (CsA) nephrotoxicity is characterized by a reduction of glomerular filtration rate (GFR), hypomagnesemia and tubular injury. The mechanisms of CsA's immunosuppressive action and presumably its nephrotoxicity are mediated through inhibition of the renal phosphatase, calcineurin. FK506 (FK), which has a different chemical structure and binding immunophilin, also inhibits calcineurin. We compared the renal effects of these drugs to those of rapamycin (RAPA), which although similar in structure and intracellular binding to FK, does not work by changing calcineurin activity. Rats were given CsA (15 mg/kg/s.c.), FK (6 mg/kg/p.o.), RAPA (3 mg/kg/p.o.) or vehicle (V) for two weeks on a low salt diet. CsA and FK strikingly decreased urinary excretion of nitric oxide, renal blood flow and GFR, whereas RAPA did not. In contrast, all these three drugs caused significant hypomagnesemia associated with inappropriately high fractional excretion of magnesium, suggesting renal magnesium wasting. In addition, with all three drugs there were lesions in the rat kidneys consisting of tubular collapse, vacuolization and nephrocalcinosis. We thus showed that only the calcineurin inhibitors produced glomerular dysfunction in an acute experimental model of nephrotoxicity. The mechanism of hypomagnesemia and tubular injury induced by all three immunosuppressive drugs is unclear but may be independent of calcineurin. The mechanism of renal vasoconstriction on the other hand may be related to inhibition of calcineurin.
Similar articles
-
Nephrotoxicity of immunosuppressants in rats: comparison of macrolides with cyclosporin.Exp Nephrol. 1994 Nov-Dec;2(6):324-33. Exp Nephrol. 1994. PMID: 7532090
-
Nephrotoxicity of cyclosporin A and FK506: inhibition of calcineurin phosphatase.Ren Physiol Biochem. 1995 May-Jun;18(3):128-39. doi: 10.1159/000173910. Ren Physiol Biochem. 1995. PMID: 7542793
-
Kidney function and morphology after short-term combination therapy with cyclosporine A, tacrolimus and sirolimus in the rat.Nephrol Dial Transplant. 2003 Mar;18(3):491-6. doi: 10.1093/ndt/18.3.491. Nephrol Dial Transplant. 2003. PMID: 12584269
-
The antimicrobial activities of cyclosporine, FK506, and rapamycin.Transplantation. 1994 Jun 27;57(12):1689-700. Transplantation. 1994. PMID: 7517076 Review. No abstract available.
-
Calcineurin inhibitor nephrotoxicity.Clin J Am Soc Nephrol. 2009 Feb;4(2):481-508. doi: 10.2215/CJN.04800908. Clin J Am Soc Nephrol. 2009. PMID: 19218475 Review.
Cited by
-
Synthesis and biological evaluation of rapamycin-derived, next generation small molecules.Medchemcomm. 2017 Nov 22;9(1):27-43. doi: 10.1039/c7md00474e. eCollection 2018 Jan 1. Medchemcomm. 2017. PMID: 30108899 Free PMC article. Review.
-
Sirolimus-associated proteinuria and renal dysfunction.Drug Saf. 2006;29(12):1153-61. doi: 10.2165/00002018-200629120-00006. Drug Saf. 2006. PMID: 17147461 Review.
-
RapaCaspase-9-based suicide gene applied to the safety of IL-1RAP CAR-T cells.Gene Ther. 2023 Sep;30(9):706-713. doi: 10.1038/s41434-023-00404-2. Epub 2023 May 12. Gene Ther. 2023. PMID: 37173386 Free PMC article.
-
Long-term kidney allograft function and survival in prednisone-free regimens: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.Clin J Am Soc Nephrol. 2012 Mar;7(3):504-12. doi: 10.2215/CJN.06940711. Epub 2012 Jan 26. Clin J Am Soc Nephrol. 2012. PMID: 22282478 Free PMC article. Clinical Trial.
-
[Primary headaches and the influence of inflammatory diseases of the CNS and their respective immunmodulatory therapy].Schmerz. 2007 Oct;21(5):415-23. doi: 10.1007/s00482-006-0520-5. Schmerz. 2007. PMID: 17265016 German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical